Introduction {#s1}
============

Gene duplication provides raw material for evolution to act upon. Even so, most duplicate genes are inactivated and become pseudogenes before fixation. The molecular mechanisms behind paralog retention and differentiation have attracted considerable attention, and several general models have been proposed, including neofunctionalization ([@bib76]; [@bib118]), gene dosage selection ([@bib22]; [@bib93]; [@bib20]), subfunctionalization by duplication-degeneration-complementation ([@bib33]), and subfunctionalization by escape from adaptive conflict ([@bib44]; [@bib27]). Theoretical studies have proposed that the fates of duplicate genes are rapidly determined after gene duplication events ([@bib73]; [@bib51]). These models generally treat the preservation of duplicate genes as a race to distinguish their functions prior to the complete inactivation of one of the redundant paralogs, either through neutral ([@bib33]; [@bib67]) or adaptive changes ([@bib18]; [@bib67]). Regardless of the initial functional changes or dosage effects facilitating the fixation of paralogs, retention is not the end of their evolutionary paths ([@bib41]; [@bib20]).

Duplicate genes continue to diverge in different lineages, providing additional evolutionary opportunities for organisms to diversify. Previously fixed copies of duplicate genes can alter their expression timing and patterns ([@bib50]; [@bib106]), change substrate affinities ([@bib110]), and switch between regulatory modules ([@bib102]). In several cases, paralogs encoding enzymes have been recruited to perform regulatory functions, such as *S. cerevisiae HXK2*, *GAL3*, and *ARG82* ([@bib36]; [@bib20]; [@bib35]). Previously differentiated developmental roles can even be transferred from one paralog to another during evolution ([@bib107]). Perhaps more significantly, long-preserved paralogs can be lost in lineage-specific manners, a common phenomenon observed across the tree of life, including in bacteria ([@bib42]), yeasts ([@bib94]), *Paramecium* ([@bib6]; [@bib70]), plants ([@bib25]), fishes ([@bib3]), and mammals ([@bib2]; [@bib13]). Although pervasive, the importance of ongoing paralog diversification to the evolution of organismal traits and phenotypes remains underappreciated.

Duplicate gene differentiation has heavily impacted the evolution of regulatory and metabolic networks ([@bib87]; [@bib111]). Paralogs have contributed to the expansion of regulatory networks ([@bib100]), the derivation of novel networks ([@bib21]; [@bib113]; [@bib86]; [@bib84]), the specialization of network regulation ([@bib63]), and the robustness of networks to perturbation ([@bib78]; [@bib28]). The WGD has even been proposed to have facilitated the evolution of an aerobic glucose fermentation strategy called Crabtree-Warburg Effect in the lineage of yeasts that includes *Saccharomyces* ([@bib22]; [@bib52]). Gene regulation and metabolism are heavily intertwined biological processes, but there are few eukaryotic models that allow for an integrated study of the ongoing differentiation of paralogous genes with regulatory and metabolic diversification ([@bib117]; [@bib20]).

The *Saccharomyces cerevisiae GAL*actose sugar utilization network is one of the most extensively studied eukaryotic regulatory and metabolic networks, and its homologous networks are evolutionarily dynamic in yeasts. In *S. cerevisiae*, it includes the three enzymes of the Leloir pathway (Gal1, Gal7, and Gal10) that catabolize galactose, the galactose transporter Gal2, and three regulators. In the absence of galactose, the transcription factor Gal4 is inhibited by the co-repressor Gal80. When galactose is present, Gal80 is sequestered by the co-inducer Gal3, allowing Gal4 to activate the expression of the *GAL* network ([@bib55]; [@bib11]; [@bib31]). Numerous studies have shown that the *GAL* networks of various yeast lineages vary in gene content ([@bib47], [@bib45]; [@bib114]) and gene activity ([@bib79]; [@bib91]). Despite these findings, the impacts of variable network architectures on the evolution of gene regulation and metabolism are not well understood.

As a model for how duplicate gene divergence creates variable network architectures, we functionally characterized the *GAL* network of *Saccharomyces uvarum* (formerly known as *Saccharomyces bayanus* var. *uvarum*) and compared it to *S. cerevisiae*. Here we show that two *GAL* network paralog pairs in *S. uvarum* have diverged to different degrees and states than their *S. cerevisiae* homologs. We further show that, unlike *S. cerevisiae*, *S. uvarum* deploys a second co-repressor that prevents over-induction of the network. *S. uvarum* mutants lacking both co-repressors revealed surprising constraints on the rapid utilization of galactose; specifically, they arrested their growth, and metabolomic investigations suggested that they experienced metabolic overload. We show that homologous constraints exist in a milder form in *S. cerevisiae*, and the degree of metabolic constraint is affected by how *GAL* network paralogs have diversified between the species. These results show how, after a hundred of million of years of preservation, two pairs of interacting duplicate genes have continued to diverge functionally in ways that broadly impact metabolism, regulatory network structures, and the future evolutionary trajectories available.

Results {#s2}
=======

*GAL* gene content and sequence differences {#s2-1}
-------------------------------------------

*S. uvarum* has orthologs encoding all regulatory and structural genes that are present in *S. cerevisiae*, but it has duplicate copies of two additional genes. The first additional duplicate gene is *GAL80B*, which is a paralog of *GAL80*; this pair of paralogs was created by the whole genome duplication (WGD) event roughly 100 million years ago ([@bib115]; [@bib69]). *GAL80B* has been retained in the *S. uvarum-Saccharomyces eubayanus* clade, but it was lost in the *S. cerevisiae*-*Saccharomyces arboricola* clade ([@bib45], [@bib47]; [@bib95]; [@bib16]; [@bib48]; [@bib64]; [@bib8]). The second one is *GAL2B*, which was created by a recent tandem duplication in *S. uvarum-S. eubayanus* clade. Both *S. cerevisiae* and *S. uvarum* also contain a pair of specialized paralogs created by the WGD, *GAL1* and *GAL3*. By comparing amino acid sequences against the *S. cerevisiae GAL* network, we found that most *GAL* genes are diverged to a similar extent ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}), except for *GAL4*, which is primarily conserved in its DNA-binding and other functionally characterized domains. None of the *S. uvarum GAL* homologs exhibited significantly elevated rates of protein sequence evolution (from previously calculated d~N~/d~S~ ratios \[[@bib15]\]), which might have otherwise suggested extensive neofunctionalization. Thus, we focused on whether and how the key regulatory genes partitioned functions differently between the two species.10.7554/eLife.19027.003Figure 1.The *S. uvarum GAL* network.(**A**) The *GAL* regulatory network. (**B**) The *GAL* or Leloir metabolic pathway. The colors show the amino acid identity of each component compared to their *S. cerevisiae* homologs (full data in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Proteins with two homologs in *S. uvarum* are split into two parts: Gal1/Gal3 and Gal80/Gal80b (also known as *Sbay_12.142* \[[@bib95]\] or *670.20* \[[@bib16]\]) are two pairs of paralogs from a WGD event, while Gal2/Gal2b (also known as *Sbay_10.165* \[[@bib95]\] or *672.62* \[[@bib16]\]) are paralogs from a recent tandem duplication event ([@bib47]).**DOI:** [http://dx.doi.org/10.7554/eLife.19027.003](10.7554/eLife.19027.003)10.7554/eLife.19027.004Figure 1---source data 1.Amino acid identity and *GAL* gene composition between *S. uvarum* and *S. cerevisiae GAL* network.Quantitative data underlying [Figure 1](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.004](10.7554/eLife.19027.004)

Less partitioned galactokinase and co-induction functions {#s2-2}
---------------------------------------------------------

In *S. cerevisiae*, the *GAL1* and *GAL3* paralogs are descended from an ancestral bi-functional protein that was both a co-inducer and a galactokinase ([@bib92]; [@bib44]). They are almost completely subfunctionalized: ScerGAL3 lost its galactokinase activity and became a dedicated co-inducer, whereas ScerGAL1 lost most of its co-inducer activity but maintains galactokinase activity ([@bib81]; [@bib82]; [@bib103]; [@bib44]; [@bib60]). Unlike ScerGal3, SuvaGal3 retains a -Ser-Ala- dipeptide in its active site that is sufficient to weakly restore galactokinase activity when added back to ScerGal3 ([@bib82]), so we hypothesized that *SuvaGAL3* encodes a functional galactokinase. To test this hypothesis, we precisely replaced the coding sequence of *ScerGAL1*, the gene encoding the sole galactokinase in *S. cerevisiae* ([@bib82]), with *SuvaGAL3* in *S. cerevisiae*. As expected, *SuvaGAL3* conferred robust growth in galactose when driven by the *ScerGAL1* promoter, suggesting that SuvaGAL3 retains galactokinase activity ([Figure 2A](#fig2){ref-type="fig"}). Nonetheless, the *S. uvarum gal1* null mutant did not grow better in 2% galactose than it did without any carbon source, a phenotype similar to the *S. cerevisiae gal1* null mutant ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), indicating that the native *GAL3* promoter expression is insufficient to support robust metabolism.10.7554/eLife.19027.005Figure 2.*SuvaGAL1* and *SuvaGAL3* are not as subfunctionalized as *ScerGAL1* and *ScerGAL3*.(**A**) *S. uvarum GAL3* likely encodes a functional galactokinase. The error bars represent standard deviations of three biological replicates. A Wilcoxon rank sum test comparing the average times to first doubling between *S. cerevisiae gal1* and *S. cerevisiae gal1∆::SuvaGAL3* was significantly different (p=5.2e-3, *n* = 6). Note that driving *ScerGAL3* from the *ScerGAL1* promoter was insufficient to support growth with galactose as the sole carbon source, but *SuvaGAL3* was sufficient. (**B**) Unlike *S. cerevisiae gal3∆*, *S. uvarum gal3∆* does not show Long-Term Adaption (LTA). Strains were cultured in SC + 2% galactose. Wilcoxon rank sum tests comparing the average times to first doubling between *S. uvarum gal3∆* and *S. uvarum* wild-type strains were significantly different (p=4.5e-5, *n* = 12). These experiments have been repeated independently at least twice with three biological replicates, but growth curves display only one representative replicate because LTA emergence is stochastic. (**C**) LTA was recapitulated in *S. uvarum gal3∆* by replacing its *GAL1* promoter with the *S. cerevisiae GAL1* promoter (left panel) or, to a much lesser extent, by replacing the coding sequence (right panel). The insets show the times to the first doubling for the strains for their respective panels. The bar colors in the inset are the same as the growth curves. To highlight strain comparisons that test discrete hypotheses, three genotypes are repeated in [Figure 2B](#fig2){ref-type="fig"} and in both panels of [Figure 2C](#fig2){ref-type="fig"}: *S. uvarum gal3∆*, *S. cerevisiae* wild-type, and *S. cerevisiae gal3∆*. Strains were cultured in SC + 2% galactose. Wilcoxon rank sum tests comparing the average times to first doubling between strains were as follows: (1) p=4.6e-4 and *n* = 9 for *S. uvarum gal3∆* versus *S. uvarum gal3∆ gal1∆::P~SuvaGAL1~-ScerGAL1*, (2) p=4.2e-5 and *n* = 12 for *S. uvarum gal3∆* versus *S. uvarum gal3∆ gal1∆::P~ScerGAL1~-SuvaGAL1*, and (3) p=0.21 and *n* = 12 for *S. uvarum gal3∆ gal1∆::P~ScerGAL1~-SuvaGAL1* versus *S. cerevisiae gal3*.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.005](10.7554/eLife.19027.005)10.7554/eLife.19027.006Figure 2---figure supplement 1.*S. uvarum* and *S. cerevisiae* have qualitatively similar *gal1* null phenotypes.'+' indicates growth after 7 days, while '−' indicates no growth after 7 days when compared to the negative control (minimal media without a carbon source) (Materials and methods). Note that driving *SuvaGAL3* from the *ScerGAL1* promoter was sufficient to support growth with galactose as the sole carbon source ([Figure 2A](#fig2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.19027.006](10.7554/eLife.19027.006)

To further examine the functional divergence between *SuvaGAL1* and *SuvaGAL3*, we knocked out *GAL3* in *S. uvarum*. Surprisingly, the *S. uvarum gal3* null mutant did not show the classic Long-Term Adaptation (LTA) phenotype of the *S. cerevisiae gal3* null mutant ([@bib105]). Instead of a growth delay of multiple days, we observed a delay of only a few hours in *S. uvarum gal3∆* relative to wild-type ([Figure 2B](#fig2){ref-type="fig"}). These results suggest that other genes in *S. uvarum* may be able to partially compensate for the deletion of *SuvaGAL3*, such as its paralog, *SuvaGAL1*. To determine whether *GAL1* differences between *S. uvarum* and *S. cerevisiae* might be responsible for the different *gal3* null phenotypes, we replaced the *SuvaGAL1* coding sequence or promoter sequence with their *ScerGAL1* counterparts in the background of *S. uvarum gal3∆*. The *ScerGAL1* promoter swap in *S. uvarum gal3∆* largely recapitulated LTA, while the *ScerGAL1* coding sequence swap extended the delay to a lesser extent ([Figure 2C](#fig2){ref-type="fig"}). Since the *GAL1-GAL10* promoter is a divergent promoter, genetic modifications (evolved or engineered) inevitably impact both genes, as well as perhaps a lncRNA previously described in *S. cerevisiae* ([@bib19]). These results suggest that differences at the *GAL1* locus, especially within this promoter, are primarily responsible for the lack of LTA in the *S. uvarum gal3∆* mutant. Overall, the data suggest that *SuvaGAL1* is functionally redundant with *SuvaGAL3* to a much greater extent than are *ScerGAL1* and *ScerGAL3*. Thus, it is likely that the homologs in the common ancestor of *S. uvarum* and *S. cerevisiae* were more functionally redundant than in modern *S. cerevisiae*, and considerable subfunctionalization between *ScerGAL1* and *ScerGAL3* happened after the divergence of *S. uvarum* and *S. cerevisiae*.

*S. uvarum* has two co-repressors with partially overlapping functions {#s2-3}
----------------------------------------------------------------------

Next, we examined the functional divergence of the other pair of paralogous regulatory genes, *SuvaGAL80* and *SuvaGAL80B*, which are homologous to the *ScerGAL80* gene that encodes the sole *GAL* gene co-repressor in *S. cerevisiae*. We first examined the expression of these two genes in the presence or absence of galactose ([Figure 3A](#fig3){ref-type="fig"}). RNA sequencing (RNA-Seq) showed that *SuvaGAL80* was expressed at a higher level than *SuvaGAL80B* in the absence of galactose (i.e. with glycerol or glucose as the sole carbon source). In contrast, in the presence of galactose, *SuvaGAL80B* was induced by 133-fold, much higher than the 6-fold induction observed for *SuvaGAL80* ([Figure 3B](#fig3){ref-type="fig"}). *S. uvarum gal80* null mutants had a shorter lag time than wild-type in galactose, as seen in *S. cerevisiae gal80* null mutants ([@bib104]; [@bib96]; [@bib45]), but *gal80b* null mutants did not ([Figure 3C](#fig3){ref-type="fig"}). Deleting *SuvaGAL80* also resulted in elevated *GAL1* expression in the non-inducing condition (i.e. 5% glycerol), while deleting *SuvaGAL80B* had no detectable effect ([Figure 3D](#fig3){ref-type="fig"}). Therefore, we conclude that *SuvaGAL80* is the main gene responsible for repressing the *GAL* network in the absence of galactose.10.7554/eLife.19027.007Figure 3.*SuvaGAL80* and *SuvaGAL80B* encode co-repressors with partially overlapping functions.(**A**) Expression divergence between *SuvaGAL80* and *SuvaGAL80B*. The bar graph on the left shows the mRNA levels (in log~2~ of Reads Per Kilobase of transcript per Million mapped reads or RPKM) of *SuvaGAL80* and *SuvaGAL80B* in SC + 2% galactose, SC + 5% glycerol, and SC + 2% glucose. Error bars represent the standard deviations of three biological replicates. (**B**) Divergent galactose induction between *SuvaGAL80* and *SuvaGAL80B*. The bar graph shows the ratio of mRNA levels between galactose (gal) and glycerol (gly), or between galactose and glucose (glu) from the data in Panel A. (**C**) Removing *SuvaGAL80* conferred rapid initial growth in galactose. The bar graph shows the average time to first doubling of three biological replicates of each genotype in SC + 2% galactose from a representative experiment. *S. uvarum gal80∆* grew significantly faster than wild-type (p=1.8e-3, *n* = 14, Wilcoxon rank sum test), but *S. uvarum gal80b∆* did not (p=0.61, *n* = 14, Wilcoxon rank sum test). (**D**) Removing *SuvaGAL80* resulted in constitutive *GAL1* expression. The histogram shows the fluorescence levels of an EGFP reporter when driven by the *S. uvarum GAL1* promoter in SC + 5% glycerol as determined by flow cytometry. (**E**) Removing *SuvaGAL80B* led to the elevated *GAL1* expression in a mixture of glucose and galactose. Flow cytometry was conducted on strains cultured in SC + 5% galactose +2% glucose. (**F**) Removing *SuvaGAL80B* caused a fitness defect in a mixture of glucose and galactose. The specific growth rate of *S. uvarum gal80b∆* was significantly lower than wild-type (p=2.7e-4, *n* = 18, Wilcoxon rank sum test). (**G**) *SuvaGAL80* and *SuvaGAL80B* were both able to partially compensate for the loss of the other in repressing conditions, but the double-knockout resulted in constitutive expression. The histogram reports flow cytometry data from strains cultured in SC + 2% glucose for 9 hr.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.007](10.7554/eLife.19027.007)10.7554/eLife.19027.008Figure 3---figure supplement 1.In SC + 2% galactose, *S. uvarum gal80∆* and *gal80b∆* had *GAL1* expression levels similar to the wild-type at mid-log phase.Flow cytometry histogram of *P~GAL1~-EGFP* fluorescence.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.008](10.7554/eLife.19027.008)

Perhaps because of its dynamic expression, the deletion mutant phenotype of *S. uvarum gal80b∆* proved condition dependent. Consistent with previous negative results ([@bib16]), no apparent phenotypic differences were observed for the *S. uvarum gal80b∆* strain when it was grown in galactose, nor were its *GAL1* expression levels altered ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Nonetheless, in a mixture of galactose and glucose, we observed elevated *GAL1* expression in *S. uvarum gal80b∆* strains, beyond the levels observed in *S. uvarum gal80∆* strains ([Figure 3E](#fig3){ref-type="fig"}). Additionally, *S. uvarum gal80b∆* grew significantly slower than wild-type after transfer from galactose to a mixture of galactose and glucose ([Figure 3F](#fig3){ref-type="fig"}), suggesting that *SuvaGAL80B* plays a specific and biologically important repressive role in conditions where it is required to prevent network over-induction. We also observed strong negative epistasis when both co-repressors were removed: the co-repressor double knockout had substantially higher *GAL1* expression than either single knockout strain or the *S. uvarum* wild-type strain in the absence of galactose ([Figure 3G](#fig3){ref-type="fig"}). Thus, *SuvaGAL80* and *SuvaGAL80B* encode partially redundant *GAL* gene co-repressors that can each partially compensate for the loss of the other. We conclude that *SuvaGAL80B* may play a minor role in the absence of galactose, but it provides important modulation in induced conditions.

Strains lacking the co-repressors arrest their growth {#s2-4}
-----------------------------------------------------

Surprisingly, knocking out both *GAL80* and *GAL80B* in *S. uvarum* resulted in a strong Temporary Growth Arrest (TGA) phenotype in galactose ([Figure 4A](#fig4){ref-type="fig"}). This result stands in sharp contrast to the observation that *S. cerevisiae gal80* null mutant strains from multiple genetic backgrounds (the lab strains S288c, W303, and R21, as well as the vineyard strain RM11-1a examined here) grew faster in galactose, a phenotype shared with *Saccharomyces kudriavzevii gal80* null mutants and attributed to the constitutive *GAL* expression ([@bib104]; [@bib96]; [@bib45]). This growth arrest was not a genetic engineering artifact; reintroducing *SuvaGAL80* completely rescued the growth arrest, and knocking out these two genes with different markers produced the same mutant phenotype ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). More importantly, introducing *ScerGAL80* completely rescued the growth arrest ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), suggesting that the TGA phenotype was not due to novel molecular functions specific to *SuvaGAL80* or *SuvaGAL80B*. Instead, the dramatically varied phenotypes imply that these two species have different regulatory or metabolic wiring for galactose metabolism.10.7554/eLife.19027.009Figure 4.The galactose-dependent temporary growth arrest phenotype of *S.uvarum gal80∆ gal80b∆*.(**A**) The Temporary Growth Arrest (TGA) phenotype in SC + 2% galactose. The averages of the log~2~ of the ratios between absorbances at each time point (OD~t~) and initial absorbances (OD~0~) for three biological replicates are shown. The error bars represent standard deviations. The inset shows the first six hours for three biological replicates each of *S. cerevisiae* wild-type and *gal80∆* (in the background of *S. cerevisiae* RM11-1a, a vineyard strain). (**B**) The degree of the TGA phenotype was concentration dependent. A representative experiment with three biological replicates is shown; the experiment has been repeated three times. (**C**) Excessive reactive oxygen species (ROS) were accumulated in *S. uvarum gal80∆ gal80b∆* during the TGA phase. ROS levels are reported as relative fluorescence and were measured 6.5 hr after inoculation into SC + 2% galactose (p=8.6e-6, *n* = 11, Wilcoxon rank sum test). The bar graph on the right shows a positive control using *S. uvarum* wild-type in YPD and YPD + 10 mM H~2~O~2~.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.009](10.7554/eLife.19027.009)10.7554/eLife.19027.010Figure 4---figure supplement 1.The TGA phenotype of *S. uvarum gal80∆ gal80b∆* can be rescued by *S. cerevisiae GAL80* or by re-introducing *SuvaGAL80*.The bar graphs show the average times to first doubling time of three biological replicates. Strains were cultured in SC + 2% galactose.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.010](10.7554/eLife.19027.010)10.7554/eLife.19027.011Figure 4---figure supplement 2.Galactose-specific global differential expression of *S. uvarum gal80∆ gal80b∆*.(**A**) *S. uvarum GAL* network comprises similar targets as the *S. cerevisiae GAL* network. The bar graph shows the log~2~ of the RPKM ratio between *S. uvarum gal80∆ gal80b∆* and wild-type in SC + 5% glycerol. Note that *GAL80* and *GAL80B* are not in the list because they were knocked out in the double mutant, but both genes contain putative Gal4 binding sites in their promoters. *GAL3* was considered differentially expressed by edgeR (p-value = 2.95e-8 in the condition of glycerol at 11.2-fold and p=2.83e-8 in glucose at 7.3-fold, both at FDR \< 1.4e-5), although it was not by EBSeq (posterior probability of being equally expressed was 0.13 in glycerol and 0.28 in glucose). The two other experimentally verified *S. cerevisiae* Gal4 target genes (*MTH1* and *PCL10*) were not considered up-regulated by either edgeR (p=0.5 at 0.9-fold for *MTH1* and p*=*0.8 at 1-fold for *PCL10* in glycerol, p=0.1 at 1.5-fold for *MTH1* and p*=*0.1 at 1.5-fold for *PCL10* in glucose, all at FDR = 1) or EBSeq (posterior probabilities of being equally expressed for *MTH1* and *PCL10* were 0.7 and 0.8 in glycerol, respectively, and 1.0 and 1.0 in glucose, respectively), despite having conserved putative Gal4 binding sites in their upstream sequences in *S. uvarum*. The three genes described as down-regulated in *S. uvarum gal80b∆* strains by Caudy *et al.*([@bib16]) were not differentially expressed in *S. uvarum gal80∆ gal80b∆* strains in our growth conditions. (**B-C**) Venn diagrams of differential expression of *S. uvarum gal80∆ gal80b∆* harvested at (**B**) the TGA phase, and (**C**) mid-log phase in SC + 2% glucose, +5% glycerol, or +2% galactose. Note that most gene expression changes were galactose-specific, suggesting that they were caused by metabolic defects, rather than direct regulation by Gal4. Note that, relative to wild-type, there were still hundreds of differentially expressed genes at the mid-log phase, but most (78%, 783 of 1006) genes that were differentially expressed during the TGA phase had returned to normal expression.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.011](10.7554/eLife.19027.011)10.7554/eLife.19027.012Figure 4---figure supplement 3.High performance liquid chromatography measurements of key metabolites in SC + 2% galactose in *S. uvarum gal80∆ gal80b∆* and wild-type during the TGA phase and after the growth resumed.Statistically significant data points are marked by asterisks (\*p\<0.05, \*\*p\<0.01, one-tailed Student's t-test). Red corresponds to ethanol, and blue corresponds to galactose; ethanol was produced by galactose catabolism, but ethanol production provided a more sensitive readout than galactose consumption in early-stage cultures. Note that *S. uvarum gal80∆ gal80b∆* produced significantly more ethanol by the 1 hr time point (before the TGA phase), but the *S. uvarum* wild-type strain produced significantly more ethanol at the 3 hr and later TGA time points.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.012](10.7554/eLife.19027.012)10.7554/eLife.19027.013Figure 4---figure supplement 4.*GAL1* expression was higher at the early stages of growth in SC + 2% galactose in the *S. uvarum gal80∆ gal80b∆* background but gradually decreased.Fluorescence levels were obtained by flow cytometry, normalized to forward scatter, and plotted as histograms. 4 hr was during the TGA phase, whereas 8 hr was approaching the end of the TGA phase.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.013](10.7554/eLife.19027.013)10.7554/eLife.19027.014Figure 4---figure supplement 5.Fructose, mannose, or glucose alone did not lead to a TGA phenotype or other growth defects.All experiments were performed in SC media with the carbon sources indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.014](10.7554/eLife.19027.014)10.7554/eLife.19027.015Figure 4---figure supplement 6.The regulation of *PGM1* by galactose was inferred as the ancestral state.(**A**) mRNA levels of *S. uvarum PGM1* and *PGM2* during mid-log phase in SC + 2% galactose, SC + 5% glycerol, and SC + 2% glucose. Note that *PGM2*, which encodes the major isoform of phosphoglucomutase, has long been known to be transcriptionally induced by \~three--four fold in galactose, but it lacks a Gal4 binding site and does not appear to be a direct target in *S. cerevisiae* ([@bib75]; [@bib92]). These features are broadly shared with *S. uvarum PGM2*, which is transcriptionally induced two-fold by galactose relative to glycerol but is not transcriptionally up-regulated in the *gal80∆ gal80b∆* mutant; nor does it have a consensus Gal4 site. (**B**) Conservation of putative Gal4 binding sites upstream of *PGM1* in *S. uvarum*, *S. eubayanus*, *S. arboricola*, and two outgroup species. The orange dot indicates the inferred loss of direct regulation of *PGM1* by Gal4 based on the presence or absence of putative Gal4 binding sites (CGGN~11~CCG). The distances upstream from the start codon are shown at the right. The putative sites are shown as red boxes at the relative position of the upstream sequences of *PGM1*. Note that, in *Kazachstania nagansihii*, the upstream intergenic region of *PGM1* ortholog is 1958 bp, an unusually long intergenic region for yeasts, and contains a divergent promoter that also drives expression of the *PMU1* ortholog.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.015](10.7554/eLife.19027.015)

To test whether the TGA phenotype was associated with *S. uvarum*-specific *GAL* network members, we performed RNA-Seq on *S. uvarum gal80∆ gal80b∆* in 2% glucose or 5% glycerol, conditions where the complete *GAL* network is expected to be constitutively expressed ([@bib104]; [@bib96]; [@bib45]). We identified genes as *GAL* network members if and only if they were: (1) significantly up-regulated in *S. uvarum gal80∆ gal80b∆* compared to the wild-type at FDR = 0.05 (35 genes); (2) up-regulated by at least two-fold (19 genes); (3) up-regulated in both glucose and glycerol (nine genes); and (4) predicted to contain Gal4 consensus binding sites (CGGN~11~CCG) upstream of their coding sequences. Using these stringent criteria, we found eight potential *GAL* network members in *S. uvarum*, seven of which were shared with *S. cerevisiae* based on previous chromatin immunoprecipitation and gene expression data (*GAL1*, *GAL2*, *GAL2B*, *GAL7*, *GAL10*, *MEL1*, and *GCY1*) ([@bib104]; [@bib88]) ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). *GAL3*, a well-established Gal4 target in *S. cerevisiae*, was considered differentially expressed using less stringent criteria, but orthologs of two other known targets were not (*MTH1* and *PCL10*). The sole novel *GAL* network member in *S. uvarum* was the *PGM1* gene, which was up-regulated 26-fold in 5% glycerol in *S. uvarum gal80∆ gal80b∆* relative to wild-type. In *S. cerevisiae*, *PGM1* encodes the minor isoform of phosphoglucomutase, which, along with Pgm2, connects the Leloir pathway to glycolysis ([Figure 1](#fig1){ref-type="fig"}). Notwithstanding the *PGM1* gene, we conclude that the *S. uvarum* and *S. cerevisiae GAL* networks have similar compositions, and the handful of differences do not seem to readily explain the remarkably strong and unexpected TGA phenotype seen in *S. uvarum* strains lacking their co-repressors.

Overactive galactose catabolism precedes widespread metabolic and regulatory defects {#s2-5}
------------------------------------------------------------------------------------

In contrast to the constitutive expression of a fairly small network of direct Gal4 targets seen during growth in glucose and glycerol, *S. uvarum gal80∆ gal80b∆* double mutants experienced global changes in gene expression that were specific to growth in galactose ([Figure 4---figure supplement 2B,C](#fig4s2){ref-type="fig"}). During the TGA phase, 1006 genes were differentially expressed in *S. uvarum gal80∆ gal80b∆* relative to wild-type (620 genes up-regulated and 386 genes down-regulated by at least two-fold with FDR = 0.05 \[[Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}\]). After the mutant resumed growth in galactose, the vast majority (78%, 783 of 1006 genes) of these genes returned to expression levels indistinguishable from wild-type, and Gene Ontology (GO) term analysis showed that most of the biological processes affected during the TGA phase returned to normal ([Supplementary file 1](#SD4-data){ref-type="supplementary-material"}). The TGA phase gene expression profile was not consistent with a global environmental stress response (e.g. nuclear ribosome biogenesis and rRNA processing were up-regulated) but instead suggested a complex and incoherent integration of the regulatory signals that govern metabolism ([Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"} and [Supplementary file 1](#SD4-data){ref-type="supplementary-material"}).

Several lines of evidence suggested that this mis-regulation might be caused by overly rapid galactose catabolism immediately prior to the TGA phase. First, the optical density of the co-repressor double mutant initially increased faster than the wild-type in galactose and only plateaued after about 1.5 hr ([Figure 4A](#fig4){ref-type="fig"}). Second, during this early growth in galactose, the co-repressor double mutant produced more ethanol than the wild-type ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Third, *GAL1* was also strongly overexpressed in the mutant early during growth in galactose, but *GAL1* expression gradually converged with the wild-type strain as the cells transitioned into the TGA phase ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Finally, the severity of the TGA phenotype depended strongly on galactose concentration ([Figure 4B](#fig4){ref-type="fig"}), and growth defects were not seen in other carbon sources ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}).

To further characterize how overly rapid galactose catabolism might lead to the TGA phenotype, we performed metabolomic analyses using mass spectrometry on co-repressor double mutant and wild-type strains cultured in 2% galactose. Prior to the TGA phase, the co-repressor double mutant accumulated galactose-1-phosphate, a known toxic intermediate of galactose metabolism ([@bib80]; [@bib24]), but this two-fold accumulation (relative to wild-type) seemed unlikely to be sufficient to explain the TGA phenotype. The level of galactose-1-phosphate in *S. uvarum gal80∆ gal80b∆* returned to normal during the TGA phase ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}) and was not nearly as strong as in *S. cerevisiae gal7∆* or *gal10∆* controls (seven- to 11-fold relative to *S. cerevisiae* wild-type) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Moreover, we did not observe gene expression signatures consistent with the previously described responses to galactose-1-phosphate toxicity (e.g., environmental stress response, unfolded protein response) ([@bib97]; [@bib26]).

Instead, both transcriptomic and metabolomic analyses revealed broad metabolic defects as bottlenecks developed downstream of the Leloir pathway. During the growth arrest, we observed increased expression of genes that encode glycolytic enzymes ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}). Key metabolic intermediates also accumulated in *S. uvarum gal80∆ gal80b∆* strains before and during growth arrest, especially in upper glycolysis and interacting pathways ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}). In particular, fructose-1,6-biphosphate accumulated significantly prior to the TGA phase (12.6-fold of wild-type levels) ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}), a bottleneck that frequently occurs when upper glycolysis outpaces lower glycolysis ([@bib109]). Under these conditions, inorganic phosphate becomes a limiting factor for growth as the 'investment' steps in upper glycolysis deplete the cells of ATP and phosphate to form sugar phosphates ([@bib101]; [@bib109]). Indeed, *S. uvarum gal80∆ gal80b∆* strains had one-fifth of the ATP as wild-type prior to the TGA phase ([Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}) and had significantly up-regulated (25-fold) expression of *PHO84*, which encodes a high-affinity phosphate transporter ([Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}).10.7554/eLife.19027.016Figure 5.Overly rapid galactose catabolism leads to metabolic overload and bottlenecks.The graph shows the metabolite levels and transcript expression for the Leloir pathway, glycolysis, trehalose cycle, glycerol biosynthesis, TCA cycle, and electron transport chain. Purple steps cost ATP or inorganic phosphate (P~i~), while green steps generate ATP or P~i~. Strains were cultured in SC + 2% galactose. The arrows are color-coded to represent the RNA-Seq gene expression differences of *S. uvarum gal80∆ gal80b∆* relative to wild-type at 4 hr (red, up in the mutant; blue, down in the mutant; black, similar to wild-type; mixed colors (e.g. black and blue) indicate that the expression of genes involved in this step differs). The boxes next to each metabolite represent the log~2~ of the metabolite concentration differences relative to wild-type over time (0.5, 1.5, 3, 5, and 16 hr, respectively). The statistical significance for metabolite levels was assessed using Student's t-tests (*n* = 3, p\<0.05 with gray reported as not significant). The 1.5 hr to 5 hr time points correspond to the TGA phase, whereas the 16 hr time point corresponds to mid-log phase after recovery from the TGA phase. ^1^, the sum of the metabolite concentrations of glycerol-3-phosphate and glycerol-2-phosphate, the latter of which is not known to be a major metabolite in *Saccharomyces*; ^2^, the sum of the metabolite levels of 3-phosphoglycerate and 2-phosphoglycerate.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.016](10.7554/eLife.19027.016)10.7554/eLife.19027.017Figure 5---source data 1.Differential gene expression between *S. uvarum gal80∆ gal80b∆* and wild-type during the TGA phase and at mid-log phase.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.017](10.7554/eLife.19027.017)10.7554/eLife.19027.018Figure 5---source data 2.Mass spectrometry metabolomic results comparing *S. uvarum gal80∆ gal80b∆* to wild-type during the TGA phase and mid-log phase.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.018](10.7554/eLife.19027.018)10.7554/eLife.19027.019Figure 5---figure supplement 1.Galactose-1-phosphate accumulation of *S. cerevisiae gal7∆* and *gal10∆*.Galactose-1-phosphate levels were quantified by mass spectrometry. Samples were harvested after 4.5 hr of growth in 2% galactose. 'LOQ' stands for "Limit of Quantification".**DOI:** [http://dx.doi.org/10.7554/eLife.19027.019](10.7554/eLife.19027.019)

*S. cerevisiae* combats metabolic overload in upper glycolysis by using two main pathways to restore phosphate pools. The trehalose cycle temporarily reroutes upper glycolysis to store sugars as trehalose ([@bib109]), while glycerol biosynthesis offers an early exit from glycolysis ([@bib66]). Disrupting the *S. cerevisiae* trehalose cycle leads to the accumulation of fructose-1,6-biphosphate, decreased ATP levels, and ultimately growth arrest due to a metabolically unbalanced state ([@bib109]; [@bib38]), metabolic changes similar to the *S. uvarum* TGA phenotype. Strikingly, both pathways experienced dramatic bottlenecks in *S. uvarum gal80∆ gal80b∆* strains before and during the TGA phase. Specifically, *S. uvarum gal80∆ gal80b∆* cells accumulated 79- to 231-fold more trehalose-6-phosphate before and during the TGA phase, while they accumulated 225-fold more glycerol-3-phosphate before the TGA phase, the latter of which lessened to some extent during the TGA phase (3- to 16-fold) ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}). These data are consistent with the hypothesis that the trehalose cycle and the glycerol biosynthesis pathway are unable to handle the metabolic overload when galactose is catabolized too rapidly in *S. uvarum* strains lacking the *GAL* network repression system.

The metabolic effects of the TGA phenotype also reverberated downstream, leading to the transcriptional down-regulation of the lower part of the TCA cycle and the electron transport chain ([Figure 5](#fig5){ref-type="fig"}). Reduced respiratory activity has been shown to increase the formation of reactive oxygen species (ROS) ([@bib9]), and the co-repressor double mutant had strong signatures of mitochondrial dysfunction. GO terms related to mitochondrial structural components, mitochondrial translation, and respiration were among the most strongly down-regulated ([Supplementary file 1](#SD4-data){ref-type="supplementary-material"}). Indeed, we observed significantly higher accumulation of ROS in *S. uvarum gal80∆ gal80b∆* during the TGA phase by using the general ROS indicator dichlorodihydrofluorescein diacetate (H~2~DCF-DA) ([Figure 4C](#fig4){ref-type="fig"}). We conclude that disconnecting *S. uvarum* galactose metabolism from the negative feedback loops normally provided by the co-repressors Gal80 and Gal80b likely allows galactose to enter the Leloir pathway and glycolysis too rapidly, leading to metabolic defects far beyond the mild accumulation of galactose-1-phosphate and deep into central metabolism.

Specific sugars can exacerbate metabolic overload {#s2-6}
-------------------------------------------------

To determine whether the TGA phenotype reflected a more general metabolic constraint imposed by the interplay between glycolysis and interacting metabolic pathways, we grew *S. uvarum gal80∆ gal80b∆* in mixtures of galactose with fructose, mannose, or glucose. Fructose, mannose, and glucose are all primarily catabolized through glycolysis, but only glucose generates glycolytic intermediates that are upstream of the trehalose cycle ([Figure 5](#fig5){ref-type="fig"}). Thus, fructose and mannose are expected to contribute directly to metabolic overload with minimal offsetting effects from the trehalose cycle. If the interaction between glycolytic load and the trehalose cycle were important to the TGA phenotype, growing the double mutant in mixtures of galactose with fructose or mannose would exacerbate the growth arrest. In contrast, if the TGA phenotype were caused by galactose-specific metabolism, the addition of these more preferred sugars would have no effect, or perhaps mitigate the TGA phenotype. Consistent with the TGA phenotype being caused by a general overloading of upper glycolysis, both fructose and mannose strongly exacerbated the TGA phenotype in *S. uvarum gal80∆ gal80b∆*, while glucose partially rescued the TGA phenotype ([Figure 6A](#fig6){ref-type="fig"}). Importantly, mixing fructose or mannose with galactose had much stronger defects than the identical amounts of galactose alone ([Figure 4B](#fig4){ref-type="fig"} and [Figure 6A](#fig6){ref-type="fig"}). Co-culturing wild-type *S. uvarum* strains in galactose with these sugars was not inherently toxic ([Figure 6A](#fig6){ref-type="fig"}), so the presence of the co-repressors allows cells to cope with this challenge. Growing *S. uvarum gal80∆ gal80b∆* in fructose, mannose, or glucose alone also did not cause growth defects ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). Moreover, deleting *GAL1* completely rescued the TGA phenotype in the co-repressor double mutant ([Figure 6B](#fig6){ref-type="fig"}), while mixtures of mannose and galactose dramatically increased the levels of ROS in *S. uvarum gal80∆ gal80b∆* ([Figure 6C](#fig6){ref-type="fig"}), implying that the phenotypic enhancement caused by this sugar mixture acts through the same mechanism observed in galactose alone. Collectively, these results suggest that overly rapid catabolism of sugars can lead to general metabolic and growth defects when the appropriate futile metabolic cycles and negative feedback regulatory loops are not able to slow down catabolism.10.7554/eLife.19027.020Figure 6.The addition of sugars downstream of the trehalose cycle exacerbated metabolic overload.(**A**) Fructose and mannose exacerbated the TGA phenotype in the *S. uvarum gal80∆ gal80b∆* background, whereas glucose partially rescued the TGA phenotype. (**B**) The *S. uvarum* TGA phenotype in galactose and fructose or mannose can be rescued by the deletion of *GAL1*. The average times to first doubling are shown for three biological replicates. The error bars represent standard deviations. *S. uvarum gal80∆ gal80b∆ gal1∆* was significantly different than *S. uvarum gal80∆ gal80b∆* in both SC + 1% galactose +1% fructose (p=4.8e-3, *n* = 6, Wilcoxon rank sum test) and SC + 1% galactose + 1% mannose (p=2.9e-3, *n* = 6, Wilcoxon rank sum test). *S. uvarum gal80∆ gal80b∆ gal1∆* was not significantly different from *S. uvarum gal1∆* in SC + 1% galactose +1% fructose (p=0.43, *n* = 6, Wilcoxon rank sum test) but was marginally different from *S. uvarum gal1∆* in SC + 1% galactose +1% mannose (p=0.03, *n* = 6, Wilcoxon rank sum test). (**C**) Elevated accumulation of ROS in *S. uvarum gal80∆ gal80b∆* in SC + 1% galactose +1% mannose. *S. uvarum gal80∆ gal80b∆* had significantly higher ROS levels than the wild-type (p=8.6e-6, *n* = 11, Wilcoxon rank sum test). ROS levels are reported as relative fluorescence levels.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.020](10.7554/eLife.19027.020)

The less active *S. cerevisiae GAL* network is less susceptible to metabolic overload when derepressed {#s2-7}
------------------------------------------------------------------------------------------------------

We next considered whether the differences between the *GAL* networks of *S. cerevisiae* and *S. uvarum* might explain why a similar phenotype had not been reported for *S. cerevisiae* co-repressor mutants. Recent work has convincingly shown that the *S. uvarum GAL* network is more transcriptionally active than the *S. cerevisiae GAL* network, especially in non-inducing and mixed sugar conditions ([@bib16]; [@bib91]). Thus, we wondered whether *S. cerevisiae* and *S. uvarum* galactose catabolism might be under qualitatively similar constraints, even as the more poised and active state of the *S. uvarum GAL* network might render it more vulnerable to metabolic overload. First, we examined *S. cerevisiae gal80* null mutants more closely and found a similar but less-pronounced early rapid increase in optical density, followed by a brief but reproducible TGA phenotype ([Figure 4A](#fig4){ref-type="fig"}, inset). This observation was missed by earlier studies, which were focused on later time points, because *S. cerevisiae gal80* null mutants eventually grow much faster on galactose ([@bib104]; [@bib96]; [@bib45]). To test whether the weak TGA phenotype seen in *S. cerevisiae* was due to mechanistically similar metabolic constraints, we sought to exacerbate the phenotype of a *S. cerevisiae gal80∆* strain in a mixture of mannose and galactose. Indeed, the co-repressor mutant produced significantly more ROS than wild-type under these conditions ([Figure 7A](#fig7){ref-type="fig"}) and grew slightly more slowly ([Figure 7B](#fig7){ref-type="fig"}).10.7554/eLife.19027.021Figure 7.The less active *S. cerevisiae GAL1* gene is partially responsible for a subtle temporary growth arrest.(**A**) Elevated accumulation of ROS in *S. cerevisiae gal80∆* in SC + 1% galactose +1% mannose. *S. cerevisiae gal80∆* had significantly higher ROS than wild-type (p=2.3e-6, *n* = 12, Wilcoxon rank sum test). ROS levels are reported as relative fluorescence levels. (**B**) *S. cerevisiae gal80∆* grew more slowly when galactose was mixed with mannose. The average of three biological replicates from a representative experiment is shown, and the error bars represent standard deviations (p=0.028, *n* = 6, Wilcoxon rank sum test). (**C**) Both the *ScerGAL1* coding sequence and promoter are able to partially rescue the TGA phenotype. The error bars show the standard deviation of three biological replicates. (**D**) Both the *ScerGAL1* coding sequence and promoter reduced the growth rate of an otherwise wild-type strain of *S. uvarum* in SC + 2% galactose, while the reciprocal swap of the *GAL1* promoter in *S. cerevisiae* increased its growth rate. Wilcoxon rank sum tests comparing the specific growth rates of each subpanel were all significant: (1) p=2.3e-6 and *n* = 12 for *S. uvarum gal1∆::P~SuvaGAL1~-ScerGAL1* versus *S. uvarum* wild-type, (2) p=2.5e-4 and *n* = 9 for *S. uvarum gal1∆::P~ScerGAL1~-SuvaGAL1* versus *S. uvarum* wild-type, and (3) p=8.8e-3 and *n* = 9 for *S. cerevisiae gal1∆::P~SuvaGAL1~-ScerGAL1* versus *S. cerevisiae* wild-type.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.021](10.7554/eLife.19027.021)

Given the interspecific functional differences described above for *GAL1* ([Figure 2C](#fig2){ref-type="fig"}) and its role as the gatekeeper of the Leloir pathway, we hypothesized that the varied strengths of the TGA phenotype might be due to genetic differences in the *GAL1* locus. Thus, we precisely replaced the *S. uvarum GAL1* promoter or the *GAL1* coding sequence with their *S. cerevisiae* counterparts in *S. uvarum gal80∆ gal80b∆*. The *S. cerevisiae GAL1* promoter rescued the TGA phenotype to some extent, but the *GAL1* coding sequence swap was able to rescue the TGA phenotype to an even greater extent ([Figure 7C](#fig7){ref-type="fig"}). To confirm that *ScerGAL1* was less active than *SuvaGAL1* and not less toxic for other reasons, we examined the same precise allele replacements in an otherwise wild-type *S. uvarum* strain (i.e. containing functional copies of both co-repressors), as well as a precise reciprocal swap in *S. cerevisiae* replacing the *ScerGAL1* promoter with the *SuvaGAL1* promoter. Swapping the *ScerGAL1* promoter and coding sequence into *S. uvarum* both led to lower growth rates in galactose, while swapping the *SuvaGAL1* promoter into *S. cerevisiae* led to faster growth ([Figure 7D](#fig7){ref-type="fig"}). We conclude that the *S. uvarum GAL1* promoter and coding sequences both encode higher activity than their *S. cerevisiae* counterparts. Thus, differences in their *GAL* network activities at least partly explain the relative strengths of their TGA phenotypes and the constraints placed on their galactose metabolisms.

Discussion {#s3}
==========

Biodiversity offers a panoramic window to molecular biology {#s3-1}
-----------------------------------------------------------

The deep conservation of metabolism and many molecular processes contrasts sharply with the rapid turnover in the regulatory networks that sculpt organismal and phenotypic diversity. Here we have shown how numerous genetic differences between the *S. cerevisiae* and *S. uvarum GAL* networks, especially in the functions of paralogous regulatory genes, contribute to a more poised and active state in *S. uvarum* that is coupled to more robust repression system. When genes encoding the co-repressors were deleted, *S. uvarum* displayed a strong and unexpected growth arrest in galactose, likely due to metabolic overload. Even though *S. cerevisiae* produced qualitatively similar results, decades of previous research on this iconic metabolic and regulatory network overlooked their relatively mild presentation. Just as exaggerated manifestations facilitated the discoveries of transposons in maize, RNAi in *Caenorhabditis elegans*, and telomeres in *Tretrahymena* ([@bib12]), the striking phenotype observed in the non-traditional model organism *S. uvarum* allowed us to more fully characterize the defect caused by overly rapid galactose catabolism, while demonstrating metabolic constraints conserved across sugars and organisms.

The non-equivalence of sugars in contributing to metabolic overload {#s3-2}
-------------------------------------------------------------------

In contrast to glucose, fructose and mannose each had strikingly deleterious effects on cells that were already consuming galactose too rapidly. In *Saccharomyces*, these differences can be explained both by their effects on signaling pathways and by their entry points into glycolysis. Several glucose signaling pathways directly repress *GAL* gene transcription ([@bib54]) and increase the degradation rate of Gal2 protein ([@bib49]), both of which would serve to reduce glycolytic load. In *S. cerevisiae*, fructose and mannose do not trigger glucose repression as strongly as glucose ([@bib30]; [@bib72]). Perhaps as importantly, fructose and mannose bypass the trehalose cycle, a futile cycle recently shown to detour more than a quarter of early-stage glycolytic flux to prevent an unbalanced metabolic state and growth arrest ([@bib109]). The challenges of the catabolism of sugars other than glucose may be widespread. For example, in humans, bypassing glucose-responsive regulatory mechanisms with fructose has been associated with diabetes ([@bib68]; [@bib57]) and cancer ([@bib83]; [@bib53]).

Network architectures reflect metabolic constraints {#s3-3}
---------------------------------------------------

The intrinsic constraints imposed by galactose metabolism may have led to the evolution of regulatory mechanisms that protect against the risks of metabolic overload. Many of the differences between the *S. uvarum* and *S. cerevisiae GAL* networks can be explained as offering alternative protective strategies, while affording varied catabolic capabilities. For instance, the direct regulation of the *PGM1* gene by Gal4 would enhance the connection between the Leloir pathway and glycolysis in *S. uvarum* relative to *S. cerevisiae* ([@bib34]; [@bib77]; [@bib37]). *S. uvarum PGM1* is highly induced by galactose ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}), but this likely ancestral regulatory connection was lost in the *S. cerevisiae-S. kudriavzevii* clade ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}). Nearly all of the known differences between the *S. cerevisiae* and *S. uvarum GAL* networks make *S. uvarum* more active, including (1) apparent regulation of *PGM1* by Gal4; (2) the presence of genes encoding two galactose transporters ([Figure 1](#fig1){ref-type="fig"}); (3) the galactokinase activity of SuvaGal3 ([Figure 2A](#fig2){ref-type="fig"}); (4) the higher activity of both the *GAL1* coding and cis-regulatory sequences ([Figure 7D](#fig7){ref-type="fig"}); and (5) higher background gene expression across the network ([@bib16]; [@bib91]). Indeed, the possession of a gene encoding a second co-repressor appears to be one of the few features of the *S. uvarum GAL* network that would serve to counteract its higher activity. Thus, the dramatic up-regulation of *GAL80B* during induction may offer a robust negative feedback loop that helps prevent over-induction and metabolic overload. The retention of *GAL80B* may have allowed *S. uvarum* to maintain a more active *GAL* network, while the *S. cerevisiae GAL* network evolved lower activity.

Comparison of yeast genomes beyond the *Saccharomyces* suggests that galactose metabolism may impose similar constraints across the yeast phylogeny. The genes encoding the Leloir enzymes occur in one of the few broadly conserved yeast gene clusters ([@bib116]; [@bib98]; [@bib114]; [@bib89]), which has been suggested could promote enzyme co-regulation to prevent the accumulation of toxic intermediates ([@bib85]; [@bib58]) or ensure that only complete networks are co-inherited ([@bib61]; [@bib45]). In addition to *S. uvarum*, many yeast species that underwent the WGD retain *GAL80B* ([@bib47]). Perhaps due to these intrinsic metabolic challenges and the limited benefits of maintaining a dedicated *GAL* network, the ability to consume galactose has been lost many times across diverse yeast lineages ([@bib47], [@bib46]; [@bib98]; [@bib114]; [@bib89]).

Ongoing functional diversification of paralogs and their gene networks {#s3-4}
----------------------------------------------------------------------

In contrast to more commonly studied processes of the rapid neofunctionalization and subfunctionalization of paralogs ([@bib73]; [@bib51]), we have shown how duplicate *GAL* genes continued to diverge functionally in ways that dramatically influenced the metabolic and regulatory states of extant *Saccharomyces* species. Based on the redundancy observed between *GAL1* and *GAL3* and between *GAL80* and *GAL80B* in *S. uvarum*, we infer that the functions of these two paralog pairs overlapped more at the origin of the genus *Saccharomyces* than in *S. cerevisiae* ([Figure 8](#fig8){ref-type="fig"}). After the *S. uvarum-S. eubayanus* clade diverged from the *S. arboricola-S. cerevisiae* clade, these genes met distinct fates in different lineages ([Figure 8](#fig8){ref-type="fig"}). *GAL80B* was lost in the *S. cerevisiae-S. arboricola* clade, while it was retained in *S. uvarum* and *S. eubayanus* ([@bib45], [@bib47]; [@bib95]; [@bib16]; [@bib48]; [@bib64]; [@bib8]). The fates of *GAL1* and *GAL3* were still more varied. *GAL3* was lost in a European population of *S. kudriavzevii*, resulting in an induction defect, while the entire *GAL* network was lost in an East Asian population of this species that cannot consume galactose ([@bib45]). *GAL1* and *GAL3* were nearly completely subfunctionalized in *S. cerevisiae* ([@bib44]), but we have shown here that they maintain considerable redundancy in *S. uvarum*.10.7554/eLife.19027.022Figure 8.Ongoing diversification of the functions of the *GAL1*-*GAL3* and *GAL80*-*GAL80B* duplicate gene pairs in *Saccharomyces*.Important evolutionary events are shown on the cladogram. WGD, the whole genome duplication that created the two pairs of paralogs. The inferred duplicate divergence fates are shown at the bottom of the tree. The inferred timeline is depicted by the dashed line. Roughly \~100 million years ago, these two pairs of duplicate genes were fixed in the ancestral genome following a WGD event. Considerable partial redundancy was maintained in the lineage leading to the origin of the genus *Saccharomyces*. In the last \~10 million years, the fates of the duplicate genes have functionally diverged along different evolutionary trajectories. The bifunctionality of the *GAL1/GAL3* genes is represented by green for the enzymatic function and blue for the co-induction function. The color shading represents approximate functionality for experimentally characterized genes: a darker color indicates a stronger function, whereas a lighter color indicates a weaker function. The dashed circle with a cross indicates the loss of the indicated gene. Note that the *S. kudriavzevii* Asian population lost its entire *GAL* network, while the European population retained most of its *GAL* network but lost *GAL80B* and *GAL3*. The additional co-repressor in *S. uvarum* may minimize the risk of metabolic overload due to an otherwise highly active *GAL* network.**DOI:** [http://dx.doi.org/10.7554/eLife.19027.022](10.7554/eLife.19027.022)

For both paralog pairs, the ongoing functional diversification has been asymmetric. Deleting *GAL80B* and *GAL3* produced less striking phenotypes than deletion of their paralogs in *S. uvarum*, and some lineages have experienced inactivation or loss of these genes naturally. In the lineage leading to *S. cerevisiae*, Gal3 completely lost enzymatic activity, while a decrease in the promoter activity of its paralog *GAL1* reduced, but did not eliminate, its ability to induce the network rapidly. Other *GAL* genes also experienced an adaptive decrease in promoter activities in the lineage leading to *S. cerevisiae* ([@bib91]), which may have been enabled or necessitated by the loss of the secondary co-repressor encoded by *GAL80B*. Remarkably, the disparate resolutions of the functions of these paralogs did not happen soon after the WGD that created them. Instead, the diversification described here occurred within the last 10 million years of a 100 million year history, demonstrating that the echoes of duplication events continue to resonate through gene networks much longer than is generally appreciated ([@bib41]; [@bib20]).

The ongoing functional diversification of ancient paralogs likely has an even greater impact on the evolution of plants and vertebrates, where nearly all extant species are the products of multiple rounds of WGD, and differential paralog retention is widespread ([@bib2], [@bib3]; [@bib6]; [@bib13]; [@bib42]; [@bib94]; [@bib25]; [@bib70]). Molecular and genetic dissection is much more challenging in these systems, but there are hints that the diversification of ancient paralogs continues to have functional consequences for the evolution of metabolism ([@bib99]; [@bib20]) and development ([@bib56]; [@bib23]). Paralog diversification is often asymmetric as one paralog acquires a more specialized or auxiliary role ([@bib33]; [@bib73]; [@bib44]; [@bib27]; [@bib51]; [@bib20]). Even if this specialization is conditionally adaptive, the auxiliary paralog can become more susceptible to gene loss when conditions change. Paralog loss ends the saga of duplicate gene diversification, possibly forcing partially redundant functions back onto the remaining paralog, relieving paralog interference ([@bib7]), or leading to compensatory changes elsewhere in the network. Perhaps more interestingly, paralog loss eliminates redundancy and limits the long-term potential for adaptation. The ongoing evolutionary processes affecting the *GAL* paralogs show how gene duplication facilitates phenotypic change and network diversification in ways that continue to reverberate.

Materials and methods {#s4}
=====================

Strain construction {#s4-1}
-------------------

To construct *GAL* gene knockouts, we used MX cassettes (*hphMX*, *natMX*, or *kanMX*) ([@bib112]; [@bib40]) to precisely replace the coding sequence from start codon to stop codon. Transformations were based on the standard lithium acetate/PEG method optimized for *S. uvarum* (room temperature incubation, followed by a 37˚C heat shock) ([@bib39]; [@bib16]). To perform allele swaps, the coding sequence or promoter was first replaced by a selectable and counter-selectable *TK-hphMX* cassette, which does not require the prior introduction of an auxotrophy ([@bib1]). The coding sequence or promoter of the desired replacement sequence was amplified by PCR primers with overhangs homologous to the targeted genomic flanking region. In some cases, extended homology (100--300 bp) was then introduced through PCR sewing. For each *GAL1* promoter swap, we swapped the entire upstream intergenic region. Note that the *S. cerevisiae* and *S. uvarum GAL1* promoters are both divergent promoters that also regulate *GAL10* and may also impact a lncRNA previously described in *S. cerevisiae* ([@bib19]). Successful replacement strains were isolated by selecting for the loss of thymidine kinase activity by resistance to 5-fluorodeoxyuridine (FUdR), as well as the loss of resistance to hygromycin by replica plating ([@bib1]). GFP reporters were constructed in three parts: the *hphMX* cassette was placed upstream as the selection marker, the *S. uvarum GAL1* promoter was used to drive the expression of the reporter, and the reporter was a *yEGFP* (yeast Enhanced Green Fluorescence Protein) construct with a *S. cerevisiae CYC1* terminator that was amplified from FM1282 ([@bib44]; [@bib45]). GFP reporters were introduced to replace *S. uvarum gto1*, an inactive pseudogene (chr7: 767,328--766,478) orthologous to *S. cerevisiae GTO1* ([@bib95]). The modified loci of all transformants were verified by Sanger sequencing. *S. cerevisiae* is NCBITaxon:4932, *S. uvarum* is NCBITaxon:230603, and the strains used in this study are listed in [Supplementary file 2](#SD5-data){ref-type="supplementary-material"}.

Media and growth assays {#s4-2}
-----------------------

Strains were first streaked on YPD (10 g/L yeast extract, 20 g/L peptone, 20 g/L glucose, 18 g/L agar) plates from frozen glycerol stocks. Next, a single colony of each strain was cultured in synthetic complete (SC) medium plus 0.2% glucose (1.72 g/L yeast nitrogen base without amino acids, 5 g/L ammonium sulfate, 2 g/L complete dropout mix, 2 g/L glucose) for 2--3 days, a condition that does not induce and only minimally represses the *GAL* network. There were at least two biological replicates for each genotype, generally from independent transformants. These pre-cultures were washed with water and inoculated into the desired growth media in a 96 well plate. No explicit power analyses were performed to determine sample sizes or the number of replicates. Instead, each experiment was independently performed at least twice on separate days; details can be found in each legend. Biological replicates were defined as independent isogenic colonies on agar plates, which were used for subsequent precultures and growth assays; technical replicates were defined as independent growth assays from the same preculture. The absorbance of each well was read by an unshaken BMG FLUOstar Omega plate reader every 10 min at 595 nm. The number of cell divisions for each time point was calculated as log~2~\[(OD~strain−~OD~media~)/(OD~start−~OD~media~), an equation that normalized each optical density time point to its starting optical density and the optical density of the medium. The times to first doubling were calculated as the times for the optical densities to double from their normalized starting points. Specific growth rates were calculated using the Growth Curve Analysis Tool (GCAT) ([@bib14]). Replicates that failed to grow as precultures or during growth assays were considered as outliers and were excluded from subsequent analyses; no other data were excluded. For *S. cerevisiae* and *S. uvarum gal1* mutant growth assays ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), strains were pre-cultured in SC plus 0.67% fructose for 2 days and inoculated at a 1:1000 ratio into supplemented minimal medium (1.72 g/L yeast nitrogen base without amino acids, 5 g/L ammonium sulfate, 85.6 mg/L uracil, 85.6 mg/L lysine, 20 g/L galactose) plus 2% galactose or no carbon source. The growth properties of these strains were determined by subtracting the optical densities of cultures in media without a carbon source from media with galactose; differences less than 0.05 were considered as \'no growth.\' In each case, *S. cerevisiae* strains were cultured at 30˚C, while *S. uvarum* strains were cultured at 24˚C, except when they were cultured in the same 96 well plate. In these cases ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2B](#fig2){ref-type="fig"} and [Figure 4A](#fig4){ref-type="fig"}), strains were grown at 26˚C, and the results were summarized in one graph.

Flow cytometry {#s4-3}
--------------

The pre-culture and growth conditions were identical to those described above for the 96-well growth assays. At the indicated time points, 1--30 μL cultures were transferred from the 96-well plate to fresh medium of the same type in a new 96-well plate to obtain a concentration of 200--500 cells/μl for flow cytometry. There were at least three biological replicates for each genotype. The flow cytometry was conducted using a Guava EasyCyte Plus flow cytometer. Each experiment was independently conducted at least twice on separate days. The data were extracted from FCS 2.0 formatted files using FlowCore ([@bib43]) (RRID:[SCR_002205](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/a07fc61d-04f4-5843-9538-fa72690b1d23/search)). The fluorescence levels were normalized by forward scatter to control for cell size. For each genotype, histograms of normalized fluorescence levels of 6000 cells were smoothed by Kernel density estimation and plotted using the R statistical package.

RNA sequencing {#s4-4}
--------------

Strains were pre-cultured in SC plus 0.2% glucose for 2 days and inoculated into SC plus 2% galactose, 2% glucose, or 5% glycerol. Samples were harvested at the indicated time points and frozen using a dry ice/ethanol bath. Total RNA was extracted using the standard acidic phenol protocol ([@bib44]), and residual DNA was removed through DNase I treatment. Poly-A enrichment was performed with the NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB \#E7490, in the experiment to examine *S. uvarum GAL* network membership) or with the NEB Magnetic mRNA Isolation kit (NEB \#S1550, in the experiment sampled during the TGA phase and at mid-log phase in galactose). Illumina libraries were constructed using the NEB Ultra Directional RNA Library Prep Kit for Illumina (NEB \#E7420) and sequenced using the Illumina HiSeq 2500 platform. Reads were mapped onto the *S. uvarum* reference genome (CBS7001) ([@bib95]) using Bowtie version 2.2.2 with local read alignment and otherwise default settings ([@bib59]). Read counts were quantified by HTSeq version 0.6.0 ([@bib4]) (RRID:[SCR_005514](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/fcf16a2f-072b-5148-92b4-298b3d92b668/search)). Differential expression was determined using EBseq version 1.1.5 with a false discovery rate (FDR) of 0.05 ([@bib62]) (RRID:[SCR_003526](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/3bc7a109-c9d4-59f6-949a-e60a66190e68/search)). Analysis with edgeR (RRID:[SCR_012802](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/c292b930-a45f-59e9-8839-482f41c37ee3/search)) using the default settings was performed in parallel to examine known *S. cerevisiae* Gal4 targets that were not scored as differentially expressed in *S. uvarum* ([@bib90]). Differentially expressed genes were further analyzed by GO term analysis ([@bib5]; [@bib17]) (Generic GO Term Mapper, RRID:[SCR_005806](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/c3fc5d2d-78f7-51bf-9802-0d3d817fbcab/search); SGD Gene Ontology Slim Mapper, RRID:[SCR_005784](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/df94c735-9c90-53e7-83d5-4b567b79b8c2/search)). The RNA-Seq data are available at NCBI\'s SRA under accession number SRP077015.

Reactive oxygen species (ROS) measurements {#s4-5}
------------------------------------------

The pre-culture conditions were identical to those described above for the growth assays. The ROS measurement protocol was adapted from a previous study ([@bib29]). A 10 mM stock of H~2~DCFDA (2\',7\'-dichlorodihydrofluorescein diacetate) was freshly prepared in ethanol before each use. Cells were washed once and inoculated into the stated growth medium with 10 µM H~2~DCFDA. Cultures were harvested at the indicated time points. Fluorescence levels and optical densities were measured using a BMG FLUOstar Omega plate reader, which can read both fluorescence and optical density. To establish standard curves, a 2-fold serial dilution for each strain was measured. Since the standard curves suggested a linear relationship between fluorescence levels and cell number, fluorescence levels were normalized to optical densities. The *S. uvarum* wild-type strain was inoculated into YPD plus 10 mM H~2~O~2~ and into YPD only as positive and negative controls, respectively. Each experiment was independently conducted at least twice on separate days with at least three biological replicates in each experiment.

^13^C-labelled yeast metabolome extract preparation {#s4-6}
---------------------------------------------------

The ^13^C yeast metabolome extract ([@bib10]) was prepared by growing Y22-3 ([@bib71]) aerobically on YNB (-AA) + 1% ^13^C glucose. Yeast cultures were inoculated at an OD of 0.05 into ^13^C medium. Samples were harvested from each culture by centrifugation and frozen in liquid N~2~. Frozen pellets were first extracted with 750 µL of 40:40:20 ACN/MeOH/H~2~O, followed by a second extraction with 500 µL of the same extraction solvent. Extracts were pooled, centrifuged, and the supernatant was collected for later use as an internal standard for absolute metabolite quantification ([@bib10]).

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) metabolomic analyses {#s4-7}
------------------------------------------------------------------------------

Lyophilized cell culture metabolites were extracted from mutant and wild-type strains with 5 mL ice-cold 7:2:1 MeOH/CHCl~3~/H~2~O, and 100 µL of the extract was mixed with 10 µL ^13^C-labelled yeast metabolome extract. Three biological replicates were included for the *S. uvarum* strains ([Figure 5](#fig5){ref-type="fig"}), while two were included for the *S. cerevisiae* strains ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Chromatographic separations based on a previously described method ([@bib108]; [@bib65]) were carried out on an Agilent 1200 series HPLC comprising a vacuum degasser, binary pump, heated column compartment, and thermostated autosampler set to maintain 6˚C. Mobile phase A (MPA) was 0.5 mM NaOH, and mobile phase B (MPB) was 100 mM NaOH. 20 μL of intracellular extract or calibrant standard mixture was separated on a Dionex IonPac AS11-HC IC column (2.0 mm x 250 mm, 9.0 µm) held at 40°C using a flow rate of 0.35 mL/min. Metabolite elution was achieved by first holding at 5% MPB for 22.5 min to separate isobaric phosphosugar species. MPB was then linearly increased from 5% to 100% over 27.5 min to elute the remaining metabolites. MPB was held at 100% for 7 min for column cleaning followed by an 8 min re-equilibration step at 5% MPB. The LC system was coupled to a Dionex ERS 500 suppressor controlled by a Dionex Reagent-Free Controller (model RFC-10) and an Agilent 6460 A Triple Quadrupole MS. The MS was operated in negative mode, acquiring MRM scans for each metabolite. Quantification based off external standard calibration curves and correction with the ^13^C-labelled yeast standard was performed with Agilent MassHunter Quantitative Analysis software (version B.06.00).

High performance liquid chromatography (HPLC) {#s4-8}
---------------------------------------------

The pre-culture conditions were identical to those described above for the growth assays. At indicated time points, 1 mL of cells were centrifuged, and 500 μL supernatant was harvested and frozen at −80˚C. HPLC was conducted at the GLBRC Metabolomics Lab using an HPLC-RID system with an Aminex HPX-87H (BioRad, Inc. Hercules, CA) following previously described protocols ([@bib74]; [@bib32]). Instrument control, data collection and analyses were conducted using ChemStation B.04.03 software (Agilent Technologies, Inc., Palo Alto, CA).

Statistical analysis {#s4-9}
--------------------

All *p*-values, except for the RNA-Seq, metabolomics (two-sided student's t-test), and HPLC analyses (two-sided student's t-test), were calculated using a conservative two-sided nonparametric test. Specifically, we used a Wilcoxon rank sum test that allows the rank data from multiple independent experiments to be pooled to account for day-to-day variation without making assumptions about the distribution of the variance. These tests were performed using Mstat software version 6.1.4 (<http://mcardle.oncology.wisc.edu/mstat/>).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Ongoing resolution of duplicate gene functions shapes the diversification of a metabolic network\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Justin Fay (Reviewer \#1), and the evaluation has been overseen by a Reviewing Editor and Aviv Regev as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers and the Reviewing Editor agree that no additional experiments are required for the main message of the manuscript, although if data is available that addresses some of the questions raised by the reviewers, the authors should include it. The full reviews are included below as they note a number of points where clarification or modification of claims would help the reader and increase the precision with which the results and conclusions is communicated. In particular, please clarify the nature of the strains used (point \#2 of reviewer \#3) and address the relationship between the metabolic changes and the growth phenotypes (end of second paragraph of reviewer \#2: what is the evidence that metabolic overload is causal? Does this inference need to be toned down?)

*Reviewer \#1:*

The manuscript describes differences in divergence of two yeast species in their *GAL* network. Their primary finding is that *S. uvarum* has higher activity but also better repression of *GAL* genes compared to *S. cerevisiae*. The repressive component of this difference is shown to be mediated by an ancestral *GAL80b* retained in *S. uvarum* but lost in *S. cerevisiae*. Part of the higher activation is derived from differences in *GAL1*. The work represents a significance advance by dissecting differences in duplicated gene evolution and how they contribute to evolution of the *GAL* network. At a time when we are paying more attention to strain and species-level differences in genetic perturbations, the manuscript exemplifies the kinds of differences we will have to contend with and how we might take advantage of them.

Two sets of experiments make use of precise allele replacements of the *GAL1* promoter. These precise replacements are commendable since they avoid certain issues, however they have the disadvantage of *GAL10* being driven from the same promoter. Can the *GAL1* promoter swaps be attributed to *GAL1* or *GAL10* activity? While the main message of the work does not hinge on the answer, is there data that can address this or can you point this out to the reader. Replacement of the *GAL1* coding region should not be affect by this issue, although there is an interesting lncRNA that covers the *GAL* cluster and is involved in regulation (PMID: 26833086).

The reduced activity of the *GAL* genes in *S. cerevisiae* is striking. However, whenever *S. cerevisiae* is found to have loss of function I always wonder whether this is a defect specific to the lab strain. The lab strain has been found to a have a particularly long lag phase in glucose/galactose mixtures compared to other *S. cerevisiae* strains which also show less *GAL* repression as glucose levels fall (PMID: 25626068). While this concern does not require repeating the experiments in another strain background, it should be addressed in the manuscript, preferably through a single experiment: e.g. *gal80* deletion.

The evidence that *SuvaGAL3* encodes a functional galactokinase needs more support for the strength of the statements made: \"*SuvaGAL3* does indeed encode a functional galactokinase\". The *Suva gal1* null did not grow on galactose consistent with *Suva GAL3* lacking galactokinase activity. However, when *ScerGAL1* was replaced with *SuvaGAL3* there was growth, indicating sufficient activity for growth because *ScerGAL1*-promoter is strong. Either biochemical evidence is needed that *SuvaGAL3* and *ScerGAL3* differ in their activity or the control is needed where *ScerGAL3* is also overexpressed by the *Scer GAL1* promoter. A last option would be to temper this finding, since it is not essential to the main message.

*Reviewer \#2:*

This manuscript describes differences between two budding yeast species in the effects of mutations in the galactose metabolic pathway. The experiments are carefully done and together make up a sizeable body of work. The conclusions are for the most part justified, although I note some exceptions below.

The bulk of the manuscript deals with the discovery of a transient growth arrest in galactose medium in an *S. uvarum* strain in which the two paralogs of the *GAL80* repressor are deleted. This stands in contrast to the growth advantage in *S. cerevisiae* upon deletion of its one *GAL80* copy ([Figure 4](#fig4){ref-type="fig"}). Transcriptomic and metabolomic experiments show that in this *S. uvarum* double mutant in galactose, during a short burst of rapid growth followed by arrest, glycolysis is upregulated and the TCA cycle is repressed ([Figure 5](#fig5){ref-type="fig"}). Deleting *GAL1* ([Figure 6B](#fig6){ref-type="fig"}) or replacing the *GAL1* promoter with the *S. cerevisiae* allele ([Figure 7C](#fig7){ref-type="fig"}) was sufficient to rescue the transient growth arrest phenotype of the *S. uvarum* double *GAL80* mutant, at least in conditions when galactose was mixed with other sugars. Thus the *S. uvarum GAL1* promoter, seemingly by virtue of its high activity ([Figure 3G](#fig3){ref-type="fig"}), is a driver of the transient growth arrest of the *S. uvarum* double *GAL80* mutant, at least in mixed sugar media. The hyperactivity of the *S. uvarum GAL1* promoter is further underlined by the finding that only it, and not the *S. cerevisiae* allele of the *GAL1* promoter, can compensate for the loss of *GAL3* in an *S. cerevisiae* background during growth in galactose ([Figure 2B](#fig2){ref-type="fig"}). The authors\' model is that the transient growth arrest phenotype of the *S. uvarum* double *GAL80* mutant accrues from overzealous galactose metabolism leading to a broader \"metabolic overload.\" Strictly speaking, any mechanistic role for the suite of expression and metabolite changes seen in this double mutant is not shown.

The authors make the interesting argument that the second paralog of *GAL80, GAL80b*, may have evolved in *S. uvarum* as a necessary brake on its highly active galactose metabolic program. Indeed, they show that *GAL80b* in *S. uvarum* is a stronger repressor of *GAL1* than is *GAL80* ([Figure 3E](#fig3){ref-type="fig"}). More support for fitness-relevant functions of *GAL80b* could strengthen the manuscript. Since *GAL80* alone is sufficient to prevent the transient growth arrest that otherwise manifests in the *S. uvarum* double *GAL80* mutant in pure galactose ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), any benefit of *GAL80b* wouldn\'t be in this condition. Rather, the *GAL80b* mutant in *S. uvarum* has a slight growth defect in a mixed sugar environment ([Figure 3F](#fig3){ref-type="fig"}; it would be good to show the *GAL80* mutant also in this figure). The mechanism of the latter phenotype would be of interest here, particularly in relation to *S. uvarum\'s* hyperactive galactose metabolic program which is the theme of the work.

A first part of the manuscript, of relatively modest scope, focuses on *GAL3*, which is a regulator in *S. cerevisiae*. [Figure 2A](#fig2){ref-type="fig"} shows that *S. cerevisiae* can\'t grow in galactose when *GAL1* is deleted (an *S. uvarum GAL1* mutant is not reported). This defect can be rescued by the *S. uvarum* allele of *GAL3*, indicating a gain of metabolic function by the latter which the authors infer to be galactokinase activity.

*Reviewer \#3:*

I found this paper to be interesting and illuminating, as it captures a dynamic picture or evolution in action. We usually portray a schematic, frozen picture of evolution, focusing on the starting point (e.g. a species that diverged before the yeast WGD) and endpoint (e.g. *S. cerevisiae*). However, as shown here, analysis of multiple species that evolved in parallel shows that evolution is an ongoing process, and that divergence may take different paths, and/or occur to different levels. For example, compared to *S. cerevisiae*, the *S. uvarum GAL1* and *GAL3* genes diverged to lesser extent. However, in *S. uvarum, Gal80* duplicated, and one parallel (*GAL80B*) has diverged further towards galactose triggered expression.

The paper is clearly written, and despite technical complexity and detail-richness, makes an interesting read. The conclusions are in my view well supported, and with adequate controls that use dot be a standard but are now missing in many studies (e.g. reintroduction of the knocked out gene in a different locus to ensure the phenotype is related to this gene missing and not some other genomic perturbation). The study addressed multiple aspects including changes in transcriptome and metabolomics (including the identification of galactose-1-phosphate as the origins of toxicity). While I could imagine (and could not resist suggesting) interesting experiments that may provide further insights, I am impressed by the breadth of the data and there is no need in my view to demand additional experiments.

Comments:

1\) *GAL* gene content and sequence differences:

Reading the next section one wonders if the *S. uvarum Gal1/3* the products of the WGD? But then, the authors state: that divergence of \"*ScerGAL1* and *ScerGAL3* happened after the divergence of *S. uvarum* and *S. cerevisiae*. I suggest to explicitly discuss *Gal1/3* in this section. Further, although these are not the results of this study, still, a schematic phylogenetic tree(s) for the species and genes addressed here would really help the reader who is not familiar with yeast phylogeny and/or the *Gal* system.

2\) \"The less active *S. cerevisiae GAL* network is less susceptible to metabolic overload\" The data in this section relates to the *GAL80* knockouts of both species. Wouldn\'t the right comparison be the wild-types?

3\) Related to the above: Galactose catabolism in *S. uvarum* can be highly activated compared to *S. cerevisiae*. This is clearly demonstrated by the individual growth curves ([Figure 4](#fig4){ref-type="fig"}). Still, one wonders if, when mixed, these two species will show growth dynamics that are consistent with *S. uvarum* winning the competition at high galactose, but may be *S. cerevisiae* winning at low galactose plus glucose (or mannose, fructose)? Or maybe, *S. uvarum\'s GAL* network is superior across the board (I\'d expect tradeoffs, but still)? In general, direct competition may reveal a bit more about the evolutionary contexts under which the *GAL* networks diverged differently in various species, but this just a suggestion, not a request for additional data.

4\) In the subsection "*S. uvarum* has two co-repressors with partially overlapping functions", at the start of the second paragraph: why \"although\", maybe "because"?

5\) Inevitably, jargon and acronyms are used massively, and to some readers (this reviewer, for example) this comprises a hurdle. May be at least add one word to make it easier, e.g. TGA phenotype, or PGM gene.

6\) Discussion (subsection "The non-equivalence of sugars in contributing to metabolic overload", last paragraph): I\'m not sure that human metabolic defects are so relevant.

7\) Concluding paragraph: I can imagine situations where paralogue loss may also relief clashes (no immediate reference comes to mind, except that in domesticated strains prologue inactivation is quite common, as are WGDs of course).

10.7554/eLife.19027.028

Author response

The reviewers and the Reviewing Editor agree that no additional experiments are required for the main message of the manuscript, although if data is available that addresses some of the questions raised by the reviewers, the authors should include it. The full reviews are included below as they note a number of points where clarification or modification of claims would help the reader and increase the precision with which the results and conclusions is communicated.

In most cases, we were able to respond to the points raised by modifying the text, reformatting figures, or referencing published studies. In one case, we performed additional experiments so that the strains being compared were grown and analyzed together. Specifically, as suggested by Justin Fay and Reviewer \#2, in [Figure 2A](#fig2){ref-type="fig"}, we included *ScerGAL3* as a control to directly compare it with the replacement of the *ScerGAL1* coding sequence by *SuvaGAL3*.

In particular, please clarify the nature of the strains used (point \#2 of reviewer \#3).

We have added \"when derepressed\" to the subheading title of this section to make it clear that the comparisons being made are among co-repressor mutants, \"The less active *S. cerevisiae GAL* network is less susceptible to metabolic overload when derepressed\".

*And address the relationship between the metabolic changes and the growth phenotypes (end of second paragraph of reviewer \#2: what is the evidence that metabolic overload is causal? Does this inference need to be toned down?)*

We agree that we have not shown a strict causal link. We presented several orthogonal forms of evidence that rule out many trivial explanations, and we hope this study will lead to more detailed mechanistic studies in the future. Some claims were overstated in the original manuscript, so we have carefully gone through the entire text to tone down the strength of this inference. Examples are cited in the response to Reviewer \#2.

*Reviewer \#1:*

*Two sets of experiments make use of precise allele replacements of the GAL1 promoter. These precise replacements are commendable since they avoid certain issues, however they have the disadvantage of GAL10 being driven from the same promoter. Can the GAL1 promoter swaps be attributed to GAL1 or GAL10 activity? While the main message of the work does not hinge on the answer, is there data that can address this or can you point this out to the reader. Replacement of the GAL1 coding region should not be affect by this issue, although there is an interesting lncRNA that covers the GAL cluster and is involved in regulation (PMID: 26833086).*

We completely agree that our *GAL1* promoter swaps also affected the shared *GAL10* divergent promoter, a relevant fact not clearly stated in the original manuscript. We have added a sentence discussing this molecular constraint and the lncRNA, \"Since the *GAL1-GAL10* promoter is a divergent promoter, genetic modifications (evolved or engineered) inevitably impact both genes, as well as perhaps a lncRNA previously described in *S. cerevisiae* (Cloutier et al. 2016).\" We also modified the Methods, subsection "Strain construction". Interestingly, evolution has also been constrained by this divergent promoter architecture, and many mutations are expected to have jointly affected *GAL1, GAL10*, and potentially lncRNA expression. It might be an interesting mechanistic or synthetic biology question to ask whether changing *GAL1* expression would be sufficient without affecting *GAL10* or the lncRNA (e.g. by moving it to another locus), but we feel direct manipulation of the locus is the most appropriate test in this case.

Several other types of data specifically report expression from the *GAL1* side of the divergent promoter, showing that *GAL1* expression is affected, even if it is not necessarily the complete story: the previous gene expression results of Caudy et al. 2013 and Roop et al. 2016, our reporter construct data, and our RNA-Seq data.

*The reduced activity of the GAL genes in S. cerevisiae is striking. However, whenever S. cerevisiae is found to have loss of function I always wonder whether this is a defect specific to the lab strain. The lab strain has been found to a have a particularly long lag phase in glucose/galactose mixtures compared to other S. cerevisiae strains which also show less GAL repression as glucose levels fall (PMID: 25626068). While this concern does not require repeating the experiments in another strain background, it should be addressed in the manuscript, preferably through a single experiment: e.g. gal80 deletion.*

The specific experiments suggested (i.e. *gal80* deletions in additional strains of *S. cerevisiae*) could conceivably find that some strains of *S. cerevisiae* had a slightly stronger TGA phenotype than the barely detectable one we report here for the first time. Even so, previously published data and the present data suggest that multiple *S. cerevisiae* strains grow faster in galactose when the co-repressor is removed. Specifically, here we report the *gal80* mutant phenotype of *S. cerevisiae* in the RM11-1a background, a derivative of a vineyard strain (a fact now made explicit in the legend of [Figure 4A](#fig4){ref-type="fig"}, rather than just being buried in the supplement). Previous observations were made in S288c (Hittinger at al. 2010), W303 (Segre et al. 2006), and 21R (Torchia et al. 1984), a background from Jim Hopper\'s lab mainly comprised mainly of S288c. Thus, at least four studies and four (partially overlapping) genetic backgrounds have made the observation that *S. cerevisiae gal80* mutants grow faster than wild-type in galactose. *S. kudriavzevii* also shares this *gal80* mutant phenotype (Hittinger et al. 2010), which further suggests that the key difference is not specific to lab strains of *S. cerevisiae*, but is rather a difference between *S. uvarum* and yeasts that diverged later, including at least the *S. kudriavzevii-S. cerevisiae* clade. In the revised manuscript, we explicitly describe the evidence of these additional genetic backgrounds in the first paragraph of the subsection "Strains lacking the co-repressors arrest their growth".

There is also considerable evidence that the differences in *GAL* network activity and diauxic shift being examined in our study reflect strong species-level differences, rather than the apparently subtler differences between *S. cerevisiae* strains. The Wang et al. 2015 study referenced did indeed observe a range of diauxic shifts among *S. cerevisiae* strains, especially in 0.25% glucose + 0.25% galactose, conditions fairly far from the higher concentration conditions tested in our study. Our conditions were much closer to the conditions of Roop et al. 2016 (1% glucose + 1% galactose) who also observed substantial differences between *S. uvarum* (called *S. bayanus* by these authors) and *S. cerevisiae*. In contrast to Wang et al. 2015, Roop et al. 2016 observed that all *S. cerevisiae* strains examined underwent diauxic shift. Most of the examined strains by these two studies did not overlap, but strain BC187 was examined by both authors and seems highly informative about the differences between their observations. Wang et al. 2015 found BC187 to have a very limited diauxic shift in their conditions, while Roop et al. 2016 found it had a strong diauxic shift in their conditions, conditions where *S. uvarum* still had essentially no diauxic shift. It is not clear whether either condition is ecologically relevant, but each condition is clearly better tuned to revealing quantitative variation at a specific scale.

In summary, we do not doubt that there are experimental conditions where the subtler genetic variation between *S. cerevisiae* strains results in reproducible diauxic shifts, nor that future studies may uncover quantitative variation in their *gal80* mutant phenotypes. Nevertheless, we feel there is sufficient evidence that our key findings (and those of Roop et al. 2016 and Caudy et al. 2013) represent species-level divergence that differs in degree, if not kind, from the variation segregating within *S. cerevisiae*.

*The evidence that SuvaGAL3 encodes a functional galactokinase needs more support for the strength of the statements made: \"SuvaGAL3 does indeed encode a functional galactokinase\". The Suva gal1 null did not grow on galactose consistent with Suva GAL3 lacking galactokinase activity. However, when ScerGAL1 was replaced with SuvaGAL3 there was growth, indicating sufficient activity for growth because ScerGAL1-promoter is strong. Either biochemical evidence is needed that SuvaGAL3 and ScerGAL3 differ in their activity or the control is needed where ScerGAL3 is also overexpressed by the Scer GAL1 promoter. A last option would be to temper this finding, since it is not essential to the main message.*

We agree that we have not directly tested biochemical activity and have removed the cited sentence making this claim. We have also added \"likely\" to the [Figure 2A](#fig2){ref-type="fig"} legend subtitle.

The suggested control was originally done in Hittinger and Carroll 2007, previous findings not explicitly discussed in the original manuscript. We considered making a table to summarize our prior and current findings, but we felt that the clarity of the manuscript would be substantially strengthened if we redid all the relevant experiments in parallel, as well as ensuring that comparisons were not affected by being performed in different labs a decade apart. This new experiment yielded the expected results and is reported in the revised [Figure 2A](#fig2){ref-type="fig"}.

In addition to adding this experiment and eliminating the direct claim of biochemical activity, we also reordered this section (subsection "Less partitioned galactokinase and co-induction functions", first paragraph) to more clearly present the genetic evidence.

*Reviewer \#2:*

*This manuscript describes differences between two budding yeast species in the effects of mutations in the galactose metabolic pathway. The experiments are carefully done and together make up a sizeable body of work. The conclusions are for the most part justified, although I note some exceptions below.*

*The bulk of the manuscript deals with the discovery of a transient growth arrest in galactose medium in an S. uvarum strain in which the two paralogs of the GAL80 repressor are deleted. This stands in contrast to the growth advantage in S. cerevisiae upon deletion of its one GAL80 copy ([Figure 4](#fig4){ref-type="fig"}). Transcriptomic and metabolomic experiments show that in this S. uvarum double mutant in galactose, during a short burst of rapid growth followed by arrest, glycolysis is upregulated and the TCA cycle is repressed ([Figure 5](#fig5){ref-type="fig"}). Deleting GAL1 ([Figure 6B](#fig6){ref-type="fig"}) or replacing the GAL1 promoter with the S. cerevisiae allele ([Figure 7C](#fig7){ref-type="fig"}) was sufficient to rescue the transient growth arrest phenotype of the S. uvarum double GAL80 mutant, at least in conditions when galactose was mixed with other sugars. Thus the S. uvarum GAL1 promoter, seemingly by virtue of its high activity ([Figure 3G](#fig3){ref-type="fig"}), is a driver of the transient growth arrest of the S. uvarum double GAL80 mutant, at least in mixed sugar media. The hyperactivity of the S. uvarum GAL1 promoter is further underlined by the finding that only it, and not the S. cerevisiae allele of the GAL1 promoter, can compensate for the loss of GAL3 in an S. cerevisiae background during growth in galactose ([Figure 2B](#fig2){ref-type="fig"}). The authors\' model is that the transient growth arrest phenotype of the S. uvarum double GAL80 mutant accrues from overzealous galactose metabolism leading to a broader \"metabolic overload.\" Strictly speaking, any mechanistic role for the suite of expression and metabolite changes seen in this double mutant is not shown.*

As noted above in the response to the editor, we agree that we have not made a firm mechanistic link between the TGA phenotype and the suite of expression and metabolic changes. We have carefully gone through the entire manuscript and softened conclusions where needed, including the following:

1\) We changed the subheading title \"Overactive galactose catabolism causes widespread metabolic and regulatory defects\" to \"Overactive galactose catabolism precedes widespread metabolic and regulatory defects\".

2\) In the Abstract, we changed "due to overly rapid galactose catabolism" to "likely due to overly rapid galactose catabolism"

3\) In the third paragraph of the subsection "Overactive galactose catabolism precedes widespread metabolic and regulatory defects", we changed \"was insufficient to explain TGA\" to \"seemed unlikely to be sufficient to explain the TGA phenotype.\"

4\) At the end of the subsection "Specific sugars can exacerbate metabolic overload", we changed \"show\" to \"suggest\".

5\) In the subsection "Biodiversity offers a panoramic window to molecular biology", we removed "Metabolic overload led to the accumulation of \[...\] decoupled from gene regulation", rephrasing this to "\[...\] likely due to metabolic overload \[...\]".

6\) In the last paragraph of the subsection "Strains lacking the co-repressors arrest their growth", we changed \"caused by\" to \"associated with\"

7\) In the third paragraph of the subsection "Overactive galactose catabolism precedes widespread metabolic and regulatory defects", we changed \"To further test the hypothesis that overly rapid galactose catabolism caused TGA" to \" To further characterize how overly rapid galactose catabolism might lead to the TGA phenotype, \[...\]\".

8\) At the end of the subsection "Overactive galactose catabolism precedes widespread metabolic and regulatory defects", we added \"likely\".

*The authors make the interesting argument that the second paralog of GAL80, GAL80b, may have evolved in S. uvarum as a necessary brake on its highly active galactose metabolic program. Indeed, they show that GAL80b in S. uvarum is a stronger repressor of GAL1 than is GAL80 ([Figure 3E](#fig3){ref-type="fig"}). More support for fitness-relevant functions of GAL80b could strengthen the manuscript. Since GAL80 alone is sufficient to prevent the transient growth arrest that otherwise manifests in the S. uvarum double GAL80 mutant in pure galactose ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), any benefit of GAL80b wouldn\'t be in this condition. Rather, the GAL80b mutant in S. uvarum has a slight growth defect in a mixed sugar environment*

First, we note that our evidence shows *GAL80B* is playing a more important role in repression in specific mixed sugar conditions. Arriving at conditions sensitive enough to detect a defect was challenging, and previous researchers were not successful (Caudy et al. 2013). The fact that we can only detect a growth defect in some conditions does not necessarily mean that it is not playing an evolutionarily important role in other conditions. Laboratory experiments lack the precision and sensitivity of natural selection, which can select against mutations whose growth defects are approximately the inverse of the effective population size.

*([Figure 3F](#fig3){ref-type="fig"}; it would be good to show the GAL80 mutant also in this figure).*

The key finding is that *GAL80B* is required for a wild-type growth rate in at least one condition, a condition where a second braking mechanism is beneficial. If *gal80* mutants also had a quantitative effect in this condition, it is not clear that this result would change this conclusion (unfortunately, for this reason, that potentially interesting experiment has not been done). We note that [Figure 3E](#fig3){ref-type="fig"} shows that *gal80b* mutants have more of an effect on *GAL1* reporter expression than *gal80* mutants in mixed sugar conditions.

*The mechanism of the latter phenotype would be of interest here, particularly in relation to S. uvarum\'s hyperactive galactose metabolic program which is the theme of the work.*

Our working hypothesis is that the prominence of *GAL80B* in these conditions is largely due to its higher expression in the presence of galactose, rather than stronger protein activity per se. We have rephrased the last paragraph of the subsection "*S. uvarum* has two co-repressors with partially overlapping functions" to help highlight this view, \"Perhaps because of its dynamic expression, the deletion mutant phenotype of *S. uvarum gal80b∆* proved condition dependent.\" We agree that it is too preliminary to firmly conclude anything about this mechanism, but it would make for an interesting future study.

*A first part of the manuscript, of relatively modest scope, focuses on GAL3, which is a regulator in S. cerevisiae. [Figure 2A](#fig2){ref-type="fig"} shows that S. cerevisiae can\'t grow in galactose when GAL1 is deleted (an S. uvarum GAL1 mutant is not reported).*

As in *S. cerevisiae*, the *S. uvarum gal1* mutant does not grow on galactose. This data is reported in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} and discussed in the first paragraph of the subsection "Less partitioned galactokinase and co-induction functions", which has been rewritten to improve clarity.

*This defect can be rescued by the S. uvarum allele of GAL3, indicating a gain of metabolic function by the latter which the authors infer to be galactokinase activity.*

As discussed above in the response to Justin Fay, we have added additional experiments to [Figure 2A](#fig2){ref-type="fig"} and removed the conclusion that galactokinase activity was demonstrated directly. Based on prior work in *K. lactis*, we also note that *S. cerevisiae GAL3* probably lost metabolic function, rather than it being gained by *S. uvarum GAL3*.

*Reviewer \#3:*

*The paper is clearly written, and despite technical complexity and detail-richness, makes an interesting read. The conclusions are in my view well supported, and with adequate controls that use dot be a standard but are now missing in many studies (e.g. reintroduction of the knocked out gene in a different locus to ensure the phenotype is related to this gene missing and not some other genomic perturbation). The study addressed multiple aspects including changes in transcriptome and metabolomics (including the identification of galactose-1-phosphate as the origins of toxicity). While I could imagine (and could not resist suggesting) interesting experiments that may provide further insights, I am impressed by the breadth of the data and there is no need in my view to demand additional experiments.*

We thank the reviewer for their supportive comments and appreciation of this work. We note that, although galactose-1-phosphate toxicity could be playing a minor role, metabolic defects downstream of this step are much more substantial.

*Comments:*

*1) GAL gene content and sequence differences:*

*Reading the next section one wonders if the S. uvarum Gal1/3 the products of the WGD? But then, the authors state: that divergence of \"ScerGAL1 and ScerGAL3 happened after the divergence of S. uvarum and S. cerevisiae. I suggest to explicitly discuss Gal1/3 in this section. Further, although these are not the results of this study, still, a schematic phylogenetic tree(s) for the species and genes addressed here would really help the reader who is not familiar with yeast phylogeny and/or the Gal system.*

In the subsection "GAL gene content and sequence differences" it now clearly states that *GAL1* and *GAL3* are paralogs generated by the WGD. We have also included the explanation for the inference at end of the next section, "Thus, it is likely that the homologs in the common ancestor of *S. uvarum* and *S. cerevisiae* were more functionally redundant than in modern *S. cerevisiae* \[...\]" Since these genes started to functionally diverge well before the origin of the genus *Saccharomyces*, we have softened the conclusion about *GAL1* and *GAL3* divergence, so that it reads, \"considerable subfunctionalization\", instead of \"much of the subfunctionalization\" We considered moving [Figure 8](#fig8){ref-type="fig"}, which contains the schematic phylogenetic trees, to earlier in the study; unfortunately, the main purpose of this figure is to summarize and discuss the results of the study. We hope that the added text clarifying the relationships of *GAL1* and *GAL3* and the final layout of the manuscript will make the information sufficiently accessible to readers.

*2) \"The less active S. cerevisiae GAL network is less susceptible to metabolic overload\" The data in this section relates to the GAL80 knockouts of both species. Wouldn\'t the right comparison be the wild-types?*

As discussed in the response to the editor, we have changed the title of this section by adding \"when derepressed\" to better reflect the results. We have only observed the TGA phenotype and metabolic overload in mutants; it is likely that the wild-type gene networks of both species do a decent job of preventing metabolic overload under normal conditions. The means by which the species achieve this regulation is what differs: *S. cerevisiae* has a low-activity network and less robust repression, while *S. uvarum* has a high-activity network and more robust repression.

*3) Related to the above: Galactose catabolism in S. uvarum can be highly activated compared to S. cerevisiae. This is clearly demonstrated by the individual growth curves ([Figure 4](#fig4){ref-type="fig"}). Still, one wonders if, when mixed, these two species will show growth dynamics that are consistent with S. uvarum winning the competition at high galactose, but may be S. cerevisiae winning at low galactose plus glucose (or mannose, fructose)? Or maybe, S. uvarum\'s GAL network is superior across the board (I\'d expect tradeoffs, but still)? In general, direct competition may reveal a bit more about the evolutionary contexts under which the GAL networks diverged differently in various species, but this just a suggestion, not a request for additional data.*

Direct competition experiments could prove much more sensitive for detecting some of the tradeoffs that the reviewer hypothesizes, and we agree it may be worth exploring this system further in that context. Growth curve analyses are a much less sensitive technique, so the differences that we do report are quite large indeed. Thus, the conclusions we have reached are well supported, even if there might be additional differences that we lacked sensitivity to detect. Even with this limitation, growth curves have the added benefit of being able to study the culture dynamics of an individual strain, which was key to characterizing the previously overlooked TGA phenotype.

*4) In the subsection "S. uvarum has two co-repressors with partially overlapping functions", at the start of the second paragraph: why \"although\", maybe "because"?*

We agree that \"Although\" did not quite convey our meaning, and we have rephrased this to explicitly focus on the gene expression differences between the paralogs: \" Perhaps because of its dynamic expression, \[...\]\".

*5) Inevitably, jargon and acronyms are used massively, and to some readers (this reviewer, for example) this comprises a hurdle. May be at least add one word to make it easier, e.g. TGA phenotype, or PGM gene.*

This is an excellent suggestion, and we have added \"phenotype\" or \"phase\" after each reference to TGA. We have also added \"gene\" to uses of *PGM1* where it might have been unclear from context. Most of the genes (e.g. *GAL1, GAL3, GAL80, GAL80B*) or the proteins they encode were referred to often enough in the study that we trust the readers will be able to follow it, but we welcome any other specific suggestions.

6\) Discussion (subsection "The non-equivalence of sugars in contributing to metabolic overload", last paragraph): I\'m not sure that human metabolic defects are so relevant.

We have deleted most of this paragraph. We also shortened the previous paragraph to make room for a very brief mention of the reported link between fructose overconsumption and cancer and diabetes (subsection "The non-equivalence of sugars in contributing to metabolic overload").

*7) Concluding paragraph: I can imagine situations where paralogue loss may also relief clashes (no immediate reference comes to mind, except that in domesticated strains prologue inactivation is quite common, as are WGDs of course).*

We agree that this is a very interesting idea worthy of further investigation. We could not think of a precise example either, and we do not think our system meets the criteria, at least with current data. To at least advertise this hypothesis, we now refer to the recently proposed idea of \"paralog interference\" in the last paragraph of the subsection "Ongoing functional diversification of paralogs and their gene networks". We reference a study from Sandy Johnson\'s lab that proposed specific amino acid substitutions as a way of relieving paralog interference, but one could imagine paralog loss as being another way of accomplishing this relief in certain circumstances.
